Nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic Breast cancer: Results from the tnAcity trial

1. Yardley, D.A.
2. Coleman, R.
3. Conte, P.
4. Cortes, J.
5. Brufsky, A.
6. Shtivelband, M.
7. Young, R.
8. Bengala, C.
9. Ali, H.
10. Eakel, J.
11. Schneeweiss, A.
12. De La Cruz-Merino, L.
13. Wilks, S.
14. O’Shaughnessy, J.
15. Glück, S.
16. Li, H.
17. Miller, J.
18. Barton, D.
19. Harbeck, N.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/ANNONC/MDY201 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus